81 results
Page 3 of 5
425
y7ku8
11 Jan 21
Business combination disclosure
10:50am
425
98u4j9yr
5 Jan 21
Business combination disclosure
9:36am
8-K
3tozwqbtz9
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-2.1
m3i3wy4rns9k4951
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-99.1
yvxph
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-99.1
1sf3877jn
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
wfqtogy2ul 2r
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-2.1
prtx5 7xr
15 Dec 20
Additional proxy soliciting materials
3:32pm
10-Q
wqeve7pl35jqd pssn
7 May 20
Quarterly report
4:37pm
10-K
ynb5xho4wumet
17 Mar 20
Annual report
5:27pm
6-K
EX-10.1
yl24ljk 1zbn
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
S-8
EX-99.2
6lr1uqud
22 Jul 19
Registration of securities for employees
5:17pm
20-F/A
r9n0tx
24 Apr 19
Annual report (foreign) (amended)
5:19pm
6-K
EX-1.1
7r1fz6v
14 Feb 19
Current report (foreign)
4:40pm
424B4
h558j5 niqfy
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
EX-3.2
j51f5ncbuxi 66q94
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
ysc84ld3a
11 Feb 19
Registration statement (foreign) (amended)
9:52am